In November 2017, Asana Medical, Inc. announced that they had formally changed their name to Regentys, as a more distinctive representation of their business model and underlying regenerative medicine technology.
MIAMI LAKES, FL – November 28, 2017 -- Asana Medical, Inc., ("Asana"), a regenerative medicine company developing a novel treatment for Ulcerative Colitis (“UC”), is pleased to announce that it has changed its corporate name to Regentys (“Regentys”, the “Company”). The change, which also includes a new corporate logo and branding platform, reflects the Company’s continuing vision and development of its regenerative medicine technologies portfolio, and its lead product, ExtraCellular Matrix Hydrogel (“ECMH”).
Dr. Susan G. Manella has accepted the Company’s offer to join its Medical Advisory Board. Dr. Manella will assume the board’s leadership role in managing information flow and liaising between management and medical doctors.